216 related articles for article (PubMed ID: 32966814)
1. AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication.
Rayner JO; Roberts RA; Kim J; Poklepovic A; Roberts JL; Booth L; Dent P
Biochem Pharmacol; 2020 Dec; 182():114227. PubMed ID: 32966814
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of heat shock proteins increases autophagosome formation, and reduces the expression of APP, Tau, SOD1 G93A and TDP-43.
Dent P; Booth L; Roberts JL; Poklepovic A; Cridebring D; Reiman EM
Aging (Albany NY); 2021 Jul; 13(13):17097-17117. PubMed ID: 34252884
[TBL] [Abstract][Full Text] [Related]
3. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection.
Carlos AJ; Ha DP; Yeh DW; Van Krieken R; Tseng CC; Zhang P; Gill P; Machida K; Lee AS
J Biol Chem; 2021; 296():100759. PubMed ID: 33965375
[TBL] [Abstract][Full Text] [Related]
4. AR-12 Inhibits Multiple Chaperones Concomitant With Stimulating Autophagosome Formation Collectively Preventing Virus Replication.
Booth L; Roberts JL; Ecroyd H; Tritsch SR; Bavari S; Reid SP; Proniuk S; Zukiwski A; Jacob A; Sepúlveda CS; Giovannoni F; García CC; Damonte E; González-Gallego J; Tuñón MJ; Dent P
J Cell Physiol; 2016 Oct; 231(10):2286-302. PubMed ID: 27187154
[TBL] [Abstract][Full Text] [Related]
5. AR12 increases BAG3 expression which is essential for Tau and APP degradation via LC3-associated phagocytosis and macroautophagy.
Dent P; Booth L; Roberts JL; Poklepovic A; Martinez J; Cridebring D; Reiman EM
Aging (Albany NY); 2022 Oct; 14(20):8221-8242. PubMed ID: 36227739
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
[TBL] [Abstract][Full Text] [Related]
7. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
8. OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killing.
Booth L; Cazanave SC; Hamed HA; Yacoub A; Ogretmen B; Chen CS; Grant S; Dent P
Cancer Biol Ther; 2012 Feb; 13(4):224-36. PubMed ID: 22354011
[TBL] [Abstract][Full Text] [Related]
9. Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants.
Acharya A; Pandey K; Thurman M; Klug E; Trivedi J; Sharma K; Lorson CL; Singh K; Byrareddy SN
J Virol; 2021 Nov; 95(24):e0143721. PubMed ID: 34550770
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Spike Protein-Derived Cyclic Peptides as Modulators of Spike Interaction with GRP78.
Johnson N; Pattinson C; Burgoyne K; Hijazi K; Houssen WE; Milne BF
Chembiochem; 2024 Jun; 25(12):e202300789. PubMed ID: 38613462
[TBL] [Abstract][Full Text] [Related]
11. Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions.
Bhatt AN; Kumar A; Rai Y; Kumari N; Vedagiri D; Harshan KH; Chinnadurai V; Chandna S
Life Sci; 2022 Apr; 295():120411. PubMed ID: 35181310
[TBL] [Abstract][Full Text] [Related]
12. Multi-level inhibition of coronavirus replication by chemical ER stress.
Shaban MS; Müller C; Mayr-Buro C; Weiser H; Meier-Soelch J; Albert BV; Weber A; Linne U; Hain T; Babayev I; Karl N; Hofmann N; Becker S; Herold S; Schmitz ML; Ziebuhr J; Kracht M
Nat Commun; 2021 Sep; 12(1):5536. PubMed ID: 34545074
[TBL] [Abstract][Full Text] [Related]
13. GRP78 Inhibitor YUM70 Suppresses SARS-CoV-2 Viral Entry, Spike Protein Production and Ameliorates Lung Damage.
Ha DP; Shin WJ; Hernandez JC; Neamati N; Dubeau L; Machida K; Lee AS
Viruses; 2023 May; 15(5):. PubMed ID: 37243204
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues.
Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Li N; Tian M; Jin N; Li X
J Virol; 2021 Nov; 95(24):e0153721. PubMed ID: 34550769
[TBL] [Abstract][Full Text] [Related]
15. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro.
Morokutti-Kurz M; Fröba M; Graf P; Große M; Grassauer A; Auth J; Schubert U; Prieschl-Grassauer E
PLoS One; 2021; 16(2):e0237480. PubMed ID: 33596218
[TBL] [Abstract][Full Text] [Related]
16. Identification of a druggable site on GRP78 at the GRP78-SARS-CoV-2 interface and virtual screening of compounds to disrupt that interface.
Lazou M; Hutton JR; Chakravarty A; Joseph-McCarthy D
J Comput Aided Mol Des; 2024 Jan; 38(1):6. PubMed ID: 38263499
[TBL] [Abstract][Full Text] [Related]
17. OSU-03012 stimulates PKR-like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression, attenuating its lethal actions in transformed cells.
Park MA; Yacoub A; Rahmani M; Zhang G; Hart L; Hagan MP; Calderwood SK; Sherman MY; Koumenis C; Spiegel S; Chen CS; Graf M; Curiel DT; Fisher PB; Grant S; Dent P
Mol Pharmacol; 2008 Apr; 73(4):1168-84. PubMed ID: 18182481
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry.
Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB
Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545
[TBL] [Abstract][Full Text] [Related]
19. The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication.
Clarke EC; Nofchissey RA; Ye C; Bradfute SB
Glycobiology; 2021 May; 31(4):378-384. PubMed ID: 32985653
[TBL] [Abstract][Full Text] [Related]
20. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
